In DCM models, sulforaphane could inhibit cardiomyocyte ferroptosis by upregulating ferritin and SLC7A11 levels via AMPK-mediated Nrf2 activation (38), but more evidence on the effect of sulforaphane on DCM is still needed. Here, SLC7A11 is linked to familial dilated cardiomyopathy.